Spironolactone Monitoring Schedule: Labs & Exams Your Prescriber Should Order
HealthRX.com
Ask your prescriber which potassium checks apply to you
Key numbers
- 1 weekFirst serum potassium check after starting or changing the spironolactone dose, per the Aldactone labelSource: dailymed.nlm.nih.gov, as cited Nov 7, 2026
- 0.72%Abnormal potassium rate in healthy young women taking spironolactone for acne, versus a 0.76% baselineSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
- 50 mg dailyStarting acne dose in the SAFA trial of 410 women, raised to 100 mg daily after 6 weeksSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
- 5.0 mEq/LSerum potassium ceiling for starting the 25 mg heart failure dose; a labeled use, not acneSource: dailymed.nlm.nih.gov, as cited Nov 7, 2026
See the public record for Spironolactone
At a glance
- First potassium check / Within 1 week of starting or titrating the dose [1]
- Also in the label's monitoring / Other electrolytes, uric acid, blood glucose, volume status, kidney function [1]
- Acne status / Off-label; labeled uses are heart failure, add-on hypertension, edema and hyperaldosteronism [1]
- Acne doses tested / 50 mg daily for 6 weeks, then 100 mg daily to week 24 (SAFA) [3]
- Potassium abnormalities in healthy women with acne / 0.72% of measurements vs 0.76% baseline [2]
- Contraindications / Hyperkalemia, Addison's disease, concomitant eplerenone [1]
- Closer monitoring triggers / Other potassium-raising drugs (ACE inhibitors, ARBs, NSAIDs, trimethoprim), potassium supplements or salt substitutes, kidney impairment [1]
- Most common label adverse reaction / Gynecomastia, dose-dependent, onset 1 to 2 months to over a year [1]
What the label tells a prescriber to order
The monitoring instruction in the current Aldactone label is compact: serum potassium within 1 week of initiation or titration, then regularly, and more often when spironolactone is given with other drugs that raise potassium or to a patient with impaired renal function [1]. If hyperkalemia occurs, the label's instruction is to decrease the dose or discontinue and treat the hyperkalemia [1].
Two further lines cover the rest: monitor serum electrolytes, uric acid and blood glucose periodically, and monitor volume status and renal function periodically [1]. These instructions sit in a label for class III to IV heart failure with reduced ejection fraction, add-on therapy for hypertension, edema in cirrhosis or nephrotic syndrome, and primary hyperaldosteronism [1].
Acne is off-label, so the schedule is adapted
Spironolactone is not approved for acne; the labeled uses are the four above [1]. Any schedule written for acne is the label's general instruction applied to an unlabeled use. The randomized evidence for the acne use comes from the SAFA trial, which gave 410 women with facial acne either spironolactone 50 mg daily for 6 weeks then 100 mg daily to week 24, or placebo [3]. In that trial headache was more frequent with spironolactone (20.4% vs 12.0%) and there were no serious adverse reactions [3].
What the acne studies found about potassium
A retrospective study looked at 974 healthy young women taking spironolactone for acne at two US tertiary care centers between 2000 and 2014, excluding women with cardiovascular disease, renal failure or drugs affecting the renin-angiotensin-aldosterone system [2]. There were 13 abnormal potassium values in 1,802 measurements, a rate of 0.72%, matching the 0.76% baseline rate in 1,165 healthy young women; 6 of the 13 repeated normal, and the authors concluded routine potassium monitoring has low usefulness in this group [2].
A 2017 hybrid systematic review pooled 10 randomized trials and 21 case series, all trials at high risk of bias and the evidence graded low or very low [4]. One crossover trial showed 200 mg daily beat placebo for inflamed lesions; menstrual side effects were significantly more common at 200 mg and were less frequent with a combined oral contraceptive; pooled potassium results supported the view that routine monitoring is not required in this population [4].
These findings apply only to healthy young women without cardiovascular or kidney disease and without medicines affecting the renin-angiotensin system [2]. The label identifies impaired renal function and potassium-raising medicines as reasons that more frequent monitoring may be needed [1].
Kidney function and eGFR
Spironolactone is substantially excreted by the kidney, and the label says renal impairment raises the risk of hyperkalemia and that potassium should be monitored closely [1]. For heart failure, the label says to initiate 25 mg once daily at serum potassium of 5.0 mEq/L or lower and eGFR above 50 mL/min/1.73 m², and to consider 25 mg every other day when eGFR is between 30 and 50 mL/min/1.73 m² because of hyperkalemia risk [1]. Those are heart failure doses, not acne doses, but they show where the label treats potassium and kidney function together as a decision point.
What the visit itself covers
Some of what needs watching is not on a lab slip. The label lists irregular menses or amenorrhea, breast and nipple pain, decreased libido, dizziness, headache, drowsiness, lethargy, leg cramps, nausea, vomiting, diarrhea and gastritis among reported reactions [1]. Gynecomastia is the label's most common adverse reaction: about 9% of men in RALES at a mean dose of 26 mg/day, rising with dose, with onset anywhere from 1 to 2 months to over a year, and usually reversible [1].
In a case series of 403 adult women treated for acne, menstrual adverse effects were less common among those using combined oral contraception (odds ratio 0.23, 95% CI 0.11 to 0.50), and mean drug survival was 470.7 days [5].
Blood pressure and volume status
The label says excessive diuresis may cause symptomatic dehydration, hypotension and worsening renal function, particularly in salt-depleted patients or those taking ACE inhibitors or ARBs, and that nephrotoxic drugs such as NSAIDs, aminoglycosides and cisplatin can also worsen renal function [1]. Its instruction is to monitor volume status and renal function periodically [1].
Drugs that shorten the interval
The label names several drugs that can raise potassium alongside spironolactone and lead to severe hyperkalemia: ACE inhibitors, angiotensin receptor blockers, NSAIDs, heparin and low molecular weight heparin, and trimethoprim, as well as potassium supplements and potassium-containing salt substitutes [1]. It says specifically to check serum potassium when ACE inhibitor or ARB therapy is altered [1].
Lithium is a separate issue: spironolactone reduces its renal clearance and raises the risk of lithium toxicity, and the label says to monitor lithium levels periodically during coadministration [1]. Spironolactone and its metabolites also interfere with digoxin radioimmunoassays and raise apparent digoxin exposure, so the label directs use of an assay that does not interact [1]. Cholestyramine has been associated with hyperkalemic metabolic acidosis when given with spironolactone [1].
Hormone levels, pregnancy and lactation
The label's monitoring instructions name serum electrolytes, uric acid, blood glucose, volume status and renal function; hormone panels are not among them [1]. The label does state that spironolactone binds the androgen receptor, which underlies its anti-androgenic effects [1].
On pregnancy, the label cites anti-androgenic properties and rat data showing feminization of male fetuses, and says to avoid spironolactone in pregnant women or advise a pregnant woman of the potential risk to a male fetus; limited human case reports did not show an association with major malformations [1]. On lactation, the label says spironolactone is not present in breast milk, while limited data from one lactating woman showed its metabolite canrenone in low amounts expected to be clinically inconsequential [1].
What the label's schedule looks like
- Within 1 week of starting or titrating the dose: serum potassium [1].
- Regularly thereafter: serum potassium again, and more often if a potassium-raising drug is added or kidney function is impaired [1].
- Periodically: electrolytes, uric acid, blood glucose, volume status and renal function [1].
The label does not set a separate interval for acne, which is not a labeled use [1].
Check what you know
Question 1 of 5
Score: 0 right, 0 of 5 answered
What people on Reddit report
Reddit accounts from people taking spironolactone for acne about whether their prescribers ordered potassium or other blood tests, and how often. Views differ by prescriber and by age.
My derm was dismissive of me needing blood work because I'm under 40, but my doctor said she wants me to get blood work done after being on Spiro for 2 weeks.Read the source discussion
My derm told me unless someone has documented kidney issues, they shouldn't need blood work (especially if they are under 40).Read the source discussion
It depends on the doctor's preference! I was on it for years via my obgyn without needing bloodwork, but when I switched to have it prescribed by my derm, she required yearly labs.Read the source discussion
Shortly after one of those visits, her nurse called and sternly told me to IMMEDIATELY discontinue until I went in for another blood test, because my potassium levels were above the accepted range.Read the source discussion
I started getting chest pain and heart palpitations due to high levels of potassium and stopped taking it. My derm never did blood work nor was he concerned about this but my primary care was very concerned.Read the source discussion
Questions worth asking
Soonkie the pharmacist on what to tell your prescriber before blood tests
Soonkie, a pharmacist, stresses that patients should keep all their doctor's appointments so progress can be checked. In this view, the doctor may order blood tests to check sodium and potassium levels and see how the kidneys are working. The video also warns against taking potassium supplements or potassium-based salt substitutes while on spironolactone, and against eating large amounts of potassium-rich foods. The pharmacist advises stopping the drug if pregnancy is possible without contraception or if pregnancy is suspected, and recommends adequate contraception such as the pill or an intrauterine device during treatment. The take is framed as general educational information that does not replace a doctor's advice.
Who is speaking?
Soonkie. Pharmacist, as described on the channel 'Soonkie the pharmacist' Background
Frequently asked questions
How often are blood tests needed on spironolactone for acne?
Do studies in women with acne support skipping potassium checks?
Which drugs make monitoring more frequent?
Are salt substitutes a concern with spironolactone?
Does spironolactone affect kidney function tests?
Do hormone levels need checking while on spironolactone?
Reader questions
What people actually ask
Short answers drawn from the sources this article cites.
How often should I check potassium levels on spironolactone?
Within 1 week of starting or titrating the dose, then regularly, according to the Aldactone label. The label says to check more often when spironolactone is given with other drugs that raise potassium or to a patient with impaired renal function. Because acne is off-label, the label sets no separate interval for acne.
Do you need bloodwork for spironolactone?
Yes, the Aldactone label calls for potassium checks and periodic monitoring of other electrolytes, uric acid, blood glucose, volume status and kidney function. For acne specifically, a retrospective study of 974 healthy young women found abnormal potassium in 0.72% of measurements, close to the 0.76% baseline, and the authors judged routine potassium monitoring to have low usefulness in that group.
What blood tests are needed for spironolactone?
The label lists serum potassium first, within 1 week of starting or titrating the dose and regularly after that. It also says to check serum electrolytes, uric acid and blood glucose periodically, and to monitor volume status and renal function periodically.
References
Show all 9 referencesHide references
- U.S. National Library of Medicine, DailyMed. Aldactone (spironolactone) tablets, Pfizer prescribing information. Aldactone (spironolactone) tablets, Pfizer label
- Plovanich M, Weng QY, Mostaghimi A. Low Usefulness of Potassium Monitoring Among Healthy Young Women Taking Spironolactone for Acne. JAMA Dermatol. 2015;151(9):941-4.
- Santer M, Lawrence M, Pyne S, Renz S, Stuart BL, Sach T, et al. Clinical and cost-effectiveness of spironolactone in treating persistent facial acne in women: SAFA double-blinded RCT. Health Technol Assess. 2024;28(56):1-86.
- Layton AM, Eady EA, Whitehouse H, Del Rosso JQ, Fedorowicz Z, van Zuuren EJ. Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review. Am J Clin Dermatol. 2017;18(2):169-191.
- Garg V, Choi JK, James WD, Barbieri JS. Long-term use of spironolactone for acne in women: A case series of 403 patients. J Am Acad Dermatol. 2021;84(5):1348-1355.
- Reddit participants. Labs w spiro (for potassium levels) (r/Spironolactone). Accessed 2026-11-11.
- Reddit participants. Potassium lab checks (r/Spironolactone). Accessed 2026-11-11.
- Reddit participants. To everyone considering/on spironolactone, PLEASE. GET. REGULAR. BLOOD. TESTS. (r/acne). Accessed 2026-11-11.
- Soonkie the pharmacist. Spironolactone | Aldactone | Spiractin|Things you MUST KNOW before starting - Pharmacist Counselling. Accessed 2026-11-11.